Hemorrhagic transformation of childhood arterial ischemic stroke

Stroke

Volumn 42, Issue 4, 2011, Pages 941-946

  Beslow, Lauren A ^a   Smith, Sabrina E ^a   Vossough, Arastoo ^a   Licht, Daniel J ^a   Kasner, Scott E ^b   Favilla, Christopher G ^b   Halperin, Aviva R ^a   Gordon, Danielle M ^a   Jones, Charlene I ^a   Cucchiara, Andrew J ^c   Ichord, Rebecca N ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

anticoagulation; arterial ischemic stroke; hemorrhagic transformation; pediatric

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTERIAL ISCHEMIC STROKE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE REGISTRY; ETHNICITY; FEMALE; HEART STROKE VOLUME; HEMORRHAGIC TRANSFORMATION; HISPANIC; HUMAN; INFANT; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MOYAMOYA DISEASE; NEUROIMAGING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SICKLE CELL ANEMIA; SYMPTOM; SYSTOLIC BLOOD PRESSURE; THROMBOPHILIA; VASCULITIS;

ADOLESCENT; AGE DISTRIBUTION; AGE FACTORS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 79954588643     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.604199     Document Type: Article

References (18)

1. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189-194. (Pubitemid 36875299)
2. Low molecular weight heparinoid, Org 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The publications committee for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) investigators. JAMA. 1998;279:1265-1272.
3. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1997;349:1569-1581.
4. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet. 2000;355:1205-1210. (Pubitemid 30184528)
5. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, Michelson AD; American College of Chest Physicians. Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133:887S-968S. (Pubitemid 351892979)
6. Amlie-Lefond C, deVeber G, Chan AK, Benedict S, Bernard T, Carpenter J, Dowling MM, Fullerton H, Hovinga C, Kirton A, Lo W, Zamel K, Ichord R; International Pediatric Stroke Study. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009;8:530-536.
7. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER; American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the young. Stroke. 2008;39:2644-2691.
8. Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, DeVeber G, Fullerton HJ; International Pediatric Stroke Study Group. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the international pediatric stroke study. Circulation. 2009;119:1417-1423.
9. Sebire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr. 2004;16: 617-622. (Pubitemid 39552209)
10. Goldenberg NA, Bernard TJ, Fullerton HJ, Gordon A, deVeber G. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009;8:1120-1127.
11. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316-324. (Pubitemid 30341363)
12. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Ringleb AP, Lorenzano S, Manelfe C, Bozzao L. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30: 2280-2284. (Pubitemid 29517722)
13. Ganesan V, Ng V, Chong WK, Kirkham FJ, Connelly A. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child. 1999;81:295-300. (Pubitemid 29467764)
14. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31: 1116-1128. (Pubitemid 43851334)
15. Linfante I, Llinas RH, Schlaug G, Chaves C, Warach S, Caplan LR. Diffusion-weighted imaging and national institutes of health stroke scale in the acute phase of posterior-circulation stroke. Arch Neurol. 2001;58: 621-628. (Pubitemid 32295714)
16. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32: 438-441. (Pubitemid 32155231)
17. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study Registry. Stroke. 2007;38:75-79. (Pubitemid 46035609)
18. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960. (Pubitemid 27209140)